HYPERANDROGENISM

This adverse event was reported 94 times

HYPERANDROGENISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETRAVIRINE 30 0.0068
1 ETHOSUXIMIDE 3 0.0012
2 DOLUTEGRAVIR SODIUM AND LAMIVUDINE 4 0.0011
3 METYRAPONE 1 0.0010
4 TENOFOVIR DISOPROXIL FUMARATE TABLETS 8 0.0009
5 ZIDOVUDINE 7 0.0007
6 TESTOSTERONE 11 0.0005
7 ETOMIDATE INJECTION 1 0.0005
8 OSILODROSTAT 1 0.0005
9 ETOMIDATE 1 0.0004
See all drugs enriched for association with HYPERANDROGENISM